Embolic complications after radiofrequency catheter ablation
Identifieur interne : 000398 ( Istex/Corpus ); précédent : 000397; suivant : 000399Embolic complications after radiofrequency catheter ablation
Auteurs : Ranjan K. Thakur ; George J. Klein ; Raymond Yee ; Marco ZardiniSource :
- [ 0002-9149 ]
Abstract
Abstract: Although radiofrequency catheter ablation of accessory pathways is very efficacious and the procedure is well tolerated with a relatively low risk of serious complications, some concern is warranted for ablations in the left heart. The risk of systemic embolism may be quite significant despite heparinization during the procedure and therapy with 325 mg acetylsalicylic acid orally for 3 months. The issue of anticoagulation during ablation and the method and duration of therapy after ablation requires further scrutiny.
Url:
DOI: 10.1016/0002-9149(94)90373-5
Links to Exploration step
ISTEX:CFADB71E7597AD73B7943613E29B3FB8B93D65D6Le document en format XML
<record><TEI wicri:istexFullTextTei="no"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Embolic complications after radiofrequency catheter ablation</title><author><name sortKey="Thakur, Ranjan K" sort="Thakur, Ranjan K" uniqKey="Thakur R" first="Ranjan K." last="Thakur">Ranjan K. Thakur</name><affiliation><mods:affiliation>From the Department of Medicine, University of Western Ontario, London, Ontario, Canada</mods:affiliation></affiliation></author><author><name sortKey="Klein, George J" sort="Klein, George J" uniqKey="Klein G" first="George J." last="Klein">George J. Klein</name><affiliation><mods:affiliation>From the Department of Medicine, University of Western Ontario, London, Ontario, Canada</mods:affiliation></affiliation></author><author><name sortKey="Yee, Raymond" sort="Yee, Raymond" uniqKey="Yee R" first="Raymond" last="Yee">Raymond Yee</name><affiliation><mods:affiliation>From the Department of Medicine, University of Western Ontario, London, Ontario, Canada</mods:affiliation></affiliation></author><author><name sortKey="Zardini, Marco" sort="Zardini, Marco" uniqKey="Zardini M" first="Marco" last="Zardini">Marco Zardini</name><affiliation><mods:affiliation>From the Department of Medicine, University of Western Ontario, London, Ontario, Canada</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:CFADB71E7597AD73B7943613E29B3FB8B93D65D6</idno><date when="1994" year="1994">1994</date><idno type="doi">10.1016/0002-9149(94)90373-5</idno><idno type="url">https://api-v5.istex.fr/document/CFADB71E7597AD73B7943613E29B3FB8B93D65D6/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">000398</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000398</idno></publicationStmt><sourceDesc><biblStruct><analytic><author><name sortKey="Thakur, Ranjan K" sort="Thakur, Ranjan K" uniqKey="Thakur R" first="Ranjan K." last="Thakur">Ranjan K. Thakur</name><affiliation><mods:affiliation>From the Department of Medicine, University of Western Ontario, London, Ontario, Canada</mods:affiliation></affiliation></author><author><name sortKey="Klein, George J" sort="Klein, George J" uniqKey="Klein G" first="George J." last="Klein">George J. Klein</name><affiliation><mods:affiliation>From the Department of Medicine, University of Western Ontario, London, Ontario, Canada</mods:affiliation></affiliation></author><author><name sortKey="Yee, Raymond" sort="Yee, Raymond" uniqKey="Yee R" first="Raymond" last="Yee">Raymond Yee</name><affiliation><mods:affiliation>From the Department of Medicine, University of Western Ontario, London, Ontario, Canada</mods:affiliation></affiliation></author><author><name sortKey="Zardini, Marco" sort="Zardini, Marco" uniqKey="Zardini M" first="Marco" last="Zardini">Marco Zardini</name><affiliation><mods:affiliation>From the Department of Medicine, University of Western Ontario, London, Ontario, Canada</mods:affiliation></affiliation></author></analytic><series><idno type="ISSN">0002-9149</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0002-9149</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Abstract: Although radiofrequency catheter ablation of accessory pathways is very efficacious and the procedure is well tolerated with a relatively low risk of serious complications, some concern is warranted for ablations in the left heart. The risk of systemic embolism may be quite significant despite heparinization during the procedure and therapy with 325 mg acetylsalicylic acid orally for 3 months. The issue of anticoagulation during ablation and the method and duration of therapy after ablation requires further scrutiny.</div></front></TEI><istex><corpusName>elsevier</corpusName><author><json:item><name>Ranjan K. Thakur MD</name><affiliations><json:string>From the Department of Medicine, University of Western Ontario, London, Ontario, Canada</json:string></affiliations></json:item><json:item><name>George J. Klein MD</name><affiliations><json:string>From the Department of Medicine, University of Western Ontario, London, Ontario, Canada</json:string></affiliations></json:item><json:item><name>Raymond Yee MD</name><affiliations><json:string>From the Department of Medicine, University of Western Ontario, London, Ontario, Canada</json:string></affiliations></json:item><json:item><name>Marco Zardini MD</name><affiliations><json:string>From the Department of Medicine, University of Western Ontario, London, Ontario, Canada</json:string></affiliations></json:item></author><articleId><json:string>90373</json:string></articleId><language><json:string>eng</json:string></language><originalGenre><json:string>Short communication</json:string></originalGenre><abstract>Abstract: Although radiofrequency catheter ablation of accessory pathways is very efficacious and the procedure is well tolerated with a relatively low risk of serious complications, some concern is warranted for ablations in the left heart. The risk of systemic embolism may be quite significant despite heparinization during the procedure and therapy with 325 mg acetylsalicylic acid orally for 3 months. The issue of anticoagulation during ablation and the method and duration of therapy after ablation requires further scrutiny.</abstract><qualityIndicators><score>2.599</score><pdfWordCount>1663</pdfWordCount><pdfCharCount>10920</pdfCharCount><pdfVersion>1.3</pdfVersion><pdfPageCount>2</pdfPageCount><pdfPageSize>575.84 x 792.28 pts</pdfPageSize><refBibsNative>true</refBibsNative><abstractWordCount>78</abstractWordCount><abstractCharCount>532</abstractCharCount><keywordCount>0</keywordCount></qualityIndicators><title>Embolic complications after radiofrequency catheter ablation</title><pii><json:string>0002-9149(94)90373-5</json:string></pii><genre><json:string>brief-communication</json:string></genre><host><title>The American Journal of Cardiology</title><language><json:string>unknown</json:string></language><publicationDate>1994</publicationDate><issn><json:string>0002-9149</json:string></issn><pii><json:string>S0002-9149(00)X0929-0</json:string></pii><volume>74</volume><issue>3</issue><pages><first>278</first><last>279</last></pages><genre><json:string>journal</json:string></genre></host><categories><wos><json:string>science</json:string><json:string>cardiac & cardiovascular systems</json:string></wos><scienceMetrix><json:string>health sciences</json:string><json:string>clinical medicine</json:string><json:string>cardiovascular system & hematology</json:string></scienceMetrix><inist><json:string>sciences appliquees, technologies et medecines</json:string><json:string>sciences biologiques et medicales</json:string><json:string>sciences medicales</json:string></inist></categories><publicationDate>1994</publicationDate><copyrightDate>1994</copyrightDate><doi><json:string>10.1016/0002-9149(94)90373-5</json:string></doi><id>CFADB71E7597AD73B7943613E29B3FB8B93D65D6</id><fulltext><json:item><extension>pdf</extension><original>true</original><mimetype>application/pdf</mimetype><uri>https://api-v5.istex.fr/document/CFADB71E7597AD73B7943613E29B3FB8B93D65D6/fulltext/pdf</uri></json:item><json:item><extension>zip</extension><original>false</original><mimetype>application/zip</mimetype><uri>https://api-v5.istex.fr/document/CFADB71E7597AD73B7943613E29B3FB8B93D65D6/fulltext/zip</uri></json:item><json:item><extension>txt</extension><original>false</original><mimetype>text/plain</mimetype><uri>https://api-v5.istex.fr/document/CFADB71E7597AD73B7943613E29B3FB8B93D65D6/fulltext/txt</uri></json:item></fulltext><metadata><mods version="3.6"><titleInfo lang="en"><title>Embolic complications after radiofrequency catheter ablation</title></titleInfo><titleInfo type="alternative" lang="en" contentType="CDATA"><title>Embolic complications after radiofrequency catheter ablation</title></titleInfo><name type="personal"><namePart type="given">Ranjan K.</namePart><namePart type="family">Thakur</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>From the Department of Medicine, University of Western Ontario, London, Ontario, Canada</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">George J.</namePart><namePart type="family">Klein</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>From the Department of Medicine, University of Western Ontario, London, Ontario, Canada</affiliation><description>Dr. Klein is a Distinguished Research Professor of the Heart and Stroke Foundation.</description><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Raymond</namePart><namePart type="family">Yee</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>From the Department of Medicine, University of Western Ontario, London, Ontario, Canada</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Marco</namePart><namePart type="family">Zardini</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>From the Department of Medicine, University of Western Ontario, London, Ontario, Canada</affiliation><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre type="brief-communication" displayLabel="Short communication"></genre><originInfo><publisher>ELSEVIER</publisher><dateIssued encoding="w3cdtf">1994</dateIssued><copyrightDate encoding="w3cdtf">1994</copyrightDate></originInfo><language><languageTerm type="code" authority="iso639-2b">eng</languageTerm><languageTerm type="code" authority="rfc3066">en</languageTerm></language><physicalDescription><internetMediaType>text/html</internetMediaType></physicalDescription><abstract lang="en">Abstract: Although radiofrequency catheter ablation of accessory pathways is very efficacious and the procedure is well tolerated with a relatively low risk of serious complications, some concern is warranted for ablations in the left heart. The risk of systemic embolism may be quite significant despite heparinization during the procedure and therapy with 325 mg acetylsalicylic acid orally for 3 months. The issue of anticoagulation during ablation and the method and duration of therapy after ablation requires further scrutiny.</abstract><note>This study was supported by the Heart and Stroke Foundation of Ontario, Toronto, Canada.</note><relatedItem type="host"><titleInfo><title>The American Journal of Cardiology</title></titleInfo><titleInfo type="abbreviated"><title>AJC</title></titleInfo><genre type="journal">journal</genre><originInfo><dateIssued encoding="w3cdtf">19940801</dateIssued></originInfo><identifier type="ISSN">0002-9149</identifier><identifier type="PII">S0002-9149(00)X0929-0</identifier><part><date>19940801</date><detail type="volume"><number>74</number><caption>vol.</caption></detail><detail type="issue"><number>3</number><caption>no.</caption></detail><extent unit="issue pages"><start>211</start><end>309</end></extent><extent unit="pages"><start>278</start><end>279</end></extent></part></relatedItem><identifier type="istex">CFADB71E7597AD73B7943613E29B3FB8B93D65D6</identifier><identifier type="DOI">10.1016/0002-9149(94)90373-5</identifier><identifier type="PII">0002-9149(94)90373-5</identifier><identifier type="ArticleID">90373</identifier><accessCondition type="use and reproduction" contentType="copyright">©1994 Excerpta Medica, Inc. All rights reserved under the United States, International and Pan-American Copyright Conventions.</accessCondition><recordInfo><recordContentSource>ELSEVIER</recordContentSource><recordOrigin>Excerpta Medica, Inc. All rights reserved under the United States, International and Pan-American Copyright Conventions., ©1994</recordOrigin></recordInfo></mods></metadata><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000398 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 000398 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Canada
|area= ParkinsonCanadaV1
|flux= Istex
|étape= Corpus
|type= RBID
|clé= ISTEX:CFADB71E7597AD73B7943613E29B3FB8B93D65D6
|texte= Embolic complications after radiofrequency catheter ablation
}}
| This area was generated with Dilib version V0.6.29. |  |